MENU
+Compare
BNTX
Stock ticker: NASDAQ
AS OF
Sep 16, 04:59 PM (EDT)
Price
$99.23
Change
+$1.36 (+1.39%)
Capitalization
23.53B

BNTX BioNTech SE American Depositary Share Forecast, Technical & Fundamental Analysis

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid... Show more

BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BNTX with price predictions
Sep 15, 2025

BNTX sees MACD Histogram just turned negative

BNTX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 19, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BNTX as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

BNTX moved below its 50-day moving average on September 08, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BNTX crossed bearishly below the 50-day moving average on August 27, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BNTX entered a downward trend on September 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BNTX's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where BNTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BNTX advanced for three days, in of 284 cases, the price rose further within the following month. The odds of a continued upward trend are .

BNTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.100) is normal, around the industry mean (20.594). P/E Ratio (161.759) is within average values for comparable stocks, (53.282). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.156). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (7.077) is also within normal values, averaging (342.112).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BNTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BNTX is expected to report earnings to fall 36.25% to -101 cents per share on November 03

BioNTech SE American Depositary Share BNTX Stock Earnings Reports
Q3'25
Est.
$-1.02
Q2'25
Missed
by $0.19
Q1'25
Beat
by $0.27
Q4'24
Beat
by $0.60
Q3'24
Beat
by $2.36
The last earnings report on August 04 showed earnings per share of -160 cents, missing the estimate of -140 cents. With 1.17M shares outstanding, the current market capitalization sits at 23.53B.
A.I.Advisor
published Dividends

BNTX paid dividends on June 17, 2022

BioNTech SE American Depositary Share BNTX Stock Dividends
А dividend of $4.22 per share was paid with a record date of June 17, 2022, and an ex-dividend date of June 02, 2022. Read more...
A.I. Advisor
published General Information

General Information

a company, which focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
An der Goldgrube 12
Phone
+49 613190840
Employees
6133
Web
https://www.biontech.de
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ACES29.980.59
+2.01%
ALPS Clean Energy ETF
USOI51.490.41
+0.80%
UBS ETRACS Crude Oil Shares Cov Cll ETN
APXM30.610.09
+0.29%
FT Vest U.S. Equity Max Buffr ETF - Apr
WBND20.19N/A
N/A
Western Asset Total Return ETF
EVT24.16-0.08
-0.31%
Eaton Vance Tax-Advantaged Dividend Income Fund

BNTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with SMMT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
+1.18%
SMMT - BNTX
54%
Loosely correlated
N/A
TIL - BNTX
52%
Loosely correlated
+6.97%
MRNA - BNTX
48%
Loosely correlated
+1.57%
KYMR - BNTX
46%
Loosely correlated
+0.62%
NVAX - BNTX
44%
Loosely correlated
+1.25%
More